Prematurity and Respiratory Outcomes Program (PROP) (U01)

The summary for the Prematurity and Respiratory Outcomes Program (PROP) (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Prematurity and Respiratory Outcomes Program (PROP) (U01): Purpose. The National Heart, Lung, and Blood Institute (NHLBI) solicits grant applications from institutions/organizations to participate in a new NHLBI Prematurity and Respiratory Outcomes Program (PROP). This cooperative, multidisciplinary scientific group will investigate hypotheses on the molecular mechanisms that contribute to respiratory disease risk of the premature newborn with the long-term goal of improving outcomes in the first year of life. The Program will consist of up to five Clinical Research Centers (CRC), a Steering Committee, and a Data Coordinating Center (DCC). CRC applicants will each propose a detailed hypothesis of a mechanism that contributes to respiratory disease risk of a defined cohort, as well as innovative molecular/functional biomarkers to define the cohort, predict the severity of respiratory outcomes for that cohort, and serve as surrogate endpoints in evaluation of risk modification. This program will require collaborations between neonatologists, pulmonologists, and scientists with expertise in cutting-edge technology (such as bioengineering, molecular genetics, or imaging). Use of the multiple PI mechanism is strongly encouraged. Mechanism of Support. This FOA will utilize the Research Project Cooperative Agreement (U01) mechanism of support. Funds Available and Anticipated Number of Awards. The NHLBI intends to commit approximately $1,500,000 total costs for FY2010. The total amount to be awarded for the Prematurity and Respiratory Outcomes Program will be a maximum of $18,500,000 total costs for the 5-year project period. It is anticipated that up to 5 CRCs and 1 DCC will be awarded.

Federal Grant Title:	Prematurity and Respiratory Outcomes Program (PROP) (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-10-007
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.838
CFDA Descriptions:	Lung Diseases Research
Current Application Deadline:	Jun 02, 2009
Original Application Deadline:	Jun 02, 2009
Posted Date:	Mar 10, 2009
Creation Date:	Mar 10, 2009
Archive Date:	Jul 03, 2009
Total Program Funding:	$18,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...; • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...; • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...; • Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...; • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models; • Lung Response to Inhaled Highly Toxic Chemicals; • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...